To further differentiate the expression of ASH1L in hepatoma cells and HSCs, IHC analysis was performed on a tissue microarray (TMA) containing 196 cases of HCC primary tumor tissues (cohort 2). This evidence concerns the gene ASH1L and hepatocellular carcinoma.